Cargando…
Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendations
The efficacy of immune checkpoint inhibitors (immunotherapy) is increasingly recognized to be linked to the composition the gut microbiome. Given the high rates of resistance, interventions targeting the gut microbiome are now being investigated for its ability to improve the efficacy of immunothera...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9213341/ https://www.ncbi.nlm.nih.gov/pubmed/35266052 http://dx.doi.org/10.1007/s00520-022-06948-0 |